Mezoo메쥬
0088M0 · KOSDAQ · ₩0088M0 · 메쥬
- Market cap
- ₩127B
- Enterprise value
- ₩123B
- P/E
- 46.0×
- P/B
- 3.1×
- Dividend yield
- 0.0%
- ROE
- 6.7%
- Net margin
- 37.4%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−82.5% from the high
₩10,370Today: ₩12,780 – ₩13,990₩73,500
Returns
- 1W−10.1%
- 1M−6.4%
- 3M+9.8%
- 6M−73.2%
- YTD−67.0%
- 1Y—
- Volume today
- 89,152
- 0.6× the 20-day average
- Traded today
- ₩1.2B
- Listed shares
- 9,881,750
- EPS (12 months)
- ₩279
- Earnings yield 2.2%
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
- SentimentMixedNews: Routine corporate filings with no clear positive or negative signal. Community: 0 bullish, 0 bearish posts this week.
- MomentumFlat-1.3% over the last month; the price is below its 20-day average.
- News impactSome3 news items and filings in two weeks; 0 rated high impact, 1 medium.
Signals describe activity, not recommendations. Not financial advice.
Mezoo stock overview
Mezoo (메쥬, KRX: 0088M0) is listed on KOSDAQ, in the Medical & precision devices sector. The company develops and supplies ambulatory remote patient monitoring (aRPM) solutions, centered on the HiCardi series of wearable patch-type patient monitors and the SmartView and LiveStudio software used to manage the data. Its shares closed at ₩12,860 on Oct 27, 2026, down 3.02% on the day, giving it a market value of ₩127B.
Key facts
- Market cap
- ₩127B
- Sector
- Medical & precision devices
- Latest price change
- −3.02%
- As of
- Oct 27, 2026
- Main business
- The company develops and supplies ambulatory remote patient monitoring (aRPM) solutions, centered on the HiCardi series of wearable patch-type patient monitors and the SmartView and LiveStudio software used to manage the data.
Quick answers about Mezoo
- What does Mezoo do?
- The company develops and supplies ambulatory remote patient monitoring (aRPM) solutions, centered on the HiCardi series of wearable patch-type patient monitors and the SmartView and LiveStudio software used to manage the data. Its remote patient monitoring business serves hospitals, where inpatients are monitored at bedside and while moving, and its Holter ECG monitoring business serves outpatient and examination settings. Domestically it sells through a distribution network built with its partner Dong-A ST, and it has also registered its devices in more than 19 countries abroad through local distributors.
- What is the market cap of Mezoo?
- The market capitalisation of Mezoo was ₩127B at the close on Oct 27, 2026.
- Who are the largest shareholders of Mezoo?
- According to the latest official filings, the largest reported holders are Park Jeong-hwan (40.21%, as of Apr 10, 2026); Jo Seong-pil (8.46%, as of Apr 1, 2026); Interbest (5.22%, as of Apr 2, 2026).
- When is the next earnings report from Mezoo?
- Korean companies rarely announce results dates in advance. Based on when Mezoo filed the same report in past years, its next annual results is expected around Mar 31, 2027.
Company profile
The company develops and supplies ambulatory remote patient monitoring (aRPM) solutions, centered on the HiCardi series of wearable patch-type patient monitors and the SmartView and LiveStudio software used to manage the data. Its remote patient monitoring business serves hospitals, where inpatients are monitored at bedside and while moving, and its Holter ECG monitoring business serves outpatient and examination settings. Domestically it sells through a distribution network built with its partner Dong-A ST, and it has also registered its devices in more than 19 countries abroad through local distributors.
Written by AI from the company's latest annual report.
- Korean name
- 메쥬
- Themes
- Medical devices
- CEO
- 박정환
- Founded
- Apr 2018
- Listed
- Mar 2026
- Listed shares
- 9,881,750
- Fiscal year ends
- Month 12
- Website
- www.me-zoo.com
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Merger Completion Report (Asset Acquisition and Transfer)Oct 28, 2026
- [Amended Filing] Major Matters Report (Decision on Acquisition of Tangible Assets)Oct 27, 2026
- [Amended Filing] Major Matters Report (Decision on Acquisition of Tangible Assets)Oct 22, 2026
- Major Matters Report (Decision on Acquisition of Tangible Assets)Sep 30, 2026
- Half-year report (Jun 2026)Aug 13, 2026
Titles in Korean until English translations are added.
Also known as: Mezoo / 메쥬 / 0088M0 / KRX:0088M0
Source: KRX statistical information